相关实验视频

Updated: Jul 13, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

在儿科脑外固体瘤中采用细胞疗法:当前的方法和未来的挑战

Elisa Zappa¹, Alice Vitali², Kathleen Anders³

¹Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

European journal of cancer (Oxford, England : 1990)

|October 13, 2023

概括

采用细胞疗法 (ACT) 显示出治疗儿科固体瘤的前景. 正在开发新的策略,以克服瘤免疫逃避和T细胞枯竭等挑战,以改善患者的治疗结果.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
细胞疗法细胞疗法

背景情况:

免疫疗法为抗常规治疗的儿科固体瘤提供了新的希望.
采用细胞疗法 (ACT),特别是与嵌合抗原受体 (CAR) T 细胞,是领先的免疫疗法方法.
儿童固体瘤由于其免疫抑制的微环境和影响ACT疗效的瘤内在因素而存在挑战.

研究的目的:

审查当前针对儿科脑外固体瘤的ACT策略.
评估有希望的ACT方法的临床前和临床证据.
确定儿童瘤学ACT的挑战和未来机会.

主要方法:

关于儿童固体瘤ACT的科学文献的综述.
分析临床试验数据和临床前研究.
讨论新的细胞工程和组合疗法策略.

主要成果:

卡尔T细胞疗法是儿童固体瘤临床研究的焦点.
瘤免疫逃避和T细胞功能障碍仍然是ACT的重大障碍.
新兴策略包括与生俱来的类似淋巴细胞,先进的细胞工程和组合疗法.

结论:

在治疗儿科固体瘤方面,ACT具有显著的潜力.
克服瘤免疫抑制和T细胞枯竭对于ACT的成功至关重要.
细胞工程和组合疗法的持续创新对于改善患有固体瘤的儿童的治疗结果至关重要.

关键词:

收养细胞疗法采用细胞疗法.在CAR-T细胞中.在 NK 细胞中,NK 细胞是 NK 细胞.在 NKT 细胞中.儿科瘤在儿童中在TCR-T细胞中.γδ T 细胞的 T 细胞

更多相关视频

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.